DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Stock

Certificat

DE000ME79EB6

Real-time Bid/Ask 12:00:52 2024-07-03 EDT
73.34 EUR / 73.37 EUR -0.59% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.16%
1 month+1.58%
Date Price Change
24-07-03 73.27 -0.70%
24-07-02 73.79 -0.01%
24-07-01 73.8 -0.15%
24-06-28 73.91 0.00%
24-06-27 73.91 -0.24%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 11:24 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME79EB
ISINDE000ME79EB6
Date issued 2024-01-22
Cap 80 $
Last trading day 2024-09-20
Maturity 2024-09-20 (79 Days)
Parity 1 : 1
Emission price 70.99
Emission volume N/A
Payment day 2024-09-27
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 42.46 %
Sideways yield 0.9425 %
Sideways yield pa 4.355 %
Outperformance point 139 $
Break even 79.09 €
Highest since issue 74.09
Lowest since issue 69.31
Spread 0.06
Spread %0.08%
Distance Cap 57.6 $
Distance Cap %+41.86%
Max. earning 0.6914
Max. earning % 0.9425 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus